Why Your Wegovy Dose Must Start at 0.25mg
Understanding the Wegovy Starter Dose Protocol
The Wegovy dose escalation begins at 0.25mg for weeks 1-4, and this cannot be skipped or accelerated. This starter dose serves as your body's introduction to semaglutide, allowing GLP-1 receptors to gradually adapt to the medication. Unlike maintenance doses, the 0.25mg starter dose focuses on tolerance building rather than maximum weight management effects. Clinical protocols demonstrate that patients who begin with the proper starter dose experience significantly fewer gastrointestinal side effects throughout their journey.
Your Wegovy dose pathway follows a precise 16-week schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance. Each step serves a specific purpose in building tolerance while gradually increasing appetite suppression. The starter dose may produce mild effects, but this gradual approach ensures you can continue treatment long-term. Many patients report feeling subtle changes in appetite during their first month, laying the foundation for significant results ahead.
Wegovy Starter Dose Pricing and Bundle Options
Our 0.25mg Wegovy starter dose costs £79.99 for a 4-week supply, with new customers using code FIRST40 at checkout. For those planning ahead, the Intro Duo bundle provides both your starter dose (0.25mg) and second-month dose (0.5mg) for £169.99, covering your first 8 weeks seamlessly. This eliminates the need for separate orders and ensures continuous treatment without gaps. The bundle approach also ensures your dose progression supply, removing concerns about availability during your crucial early weeks.
Returning customers benefit from code DOSE25 for ongoing support throughout their Wegovy dose journey. Our pricing reflects the reality that starter doses require the same pharmaceutical handling, cold-chain storage, and clinical oversight as maintenance doses. The Consistency 0.25mg bundle (×2) at £139.99 supports patients who need extended time at the starter dose, as some individuals require slower progression. All prices include clinical assessment, prescriber review, and next-day temperature-controlled delivery to your door.
Clinical Evidence Supporting Wegovy Dose Escalation
The STEP clinical trials, including the landmark study by Wilding et al. published in the New England Journal of Medicine (2021), established the safety and efficacy of gradual dose escalation starting with 0.25mg. Patients in these trials who followed the complete dose escalation protocol achieved an average weight loss of approximately 15% at 68 weeks, compared to 2.4% with placebo. The starter dose phase proved crucial for long-term adherence and success.
STEP 1 specifically demonstrated that patients beginning with the proper 0.25mg starter dose and following the full escalation schedule were more likely to complete the full study period. The gradual increase allowed participants' bodies to adapt while maintaining the lifestyle changes essential for success. These clinical trials formed the basis for NICE recommendation TA875, supporting Wegovy's use with specialist weight management when following the prescribed dose escalation.
How Wegovy Works During Your Starter Dose Phase
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for appetite regulation and glucose control. During your starter dose phase, semaglutide begins binding to GLP-1 receptors in your brain's appetite centres, gradually reducing hunger signals and increasing feelings of fullness after meals. The 0.25mg dose initiates this process gently, allowing your digestive system to adapt to slower gastric emptying—one of semaglutide's key mechanisms. You may notice subtle changes in food preferences and portion sizes even during this initial phase. The once-weekly injection maintains consistent semaglutide levels, providing steady appetite regulation throughout each week while your body prepares for higher therapeutic doses.
Your EverydayMeds Ordering Process
Beginning your Wegovy dose journey requires just a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our clinical team, operating under GPhC registration #9012878, reviews every assessment within 3 working days (or 24 hours with express review). Once approved, your starter dose ships via next-day delivery in temperature-controlled packaging, maintaining the 2-8°C storage requirements essential for semaglutide stability. You'll receive injection guidance, dose escalation scheduling, and ongoing support throughout your treatment. Our system automatically reminds you when it's time to progress to your next dose, ensuring seamless continuation of your weight management journey.
Storage and Practical Considerations for Your Starter Dose
Your Wegovy starter dose arrives in a pre-filled FlexTouch pen requiring refrigerated storage at 2-8°C until first use, after which it remains stable for up to 6 weeks at room temperature below 30°C. This storage flexibility surpasses many other GLP-1 medications, making Wegovy ideal for travel and daily life during your dose escalation phase. Each pen contains 4 weekly doses with clear dosing windows and an easy-to-use injection mechanism suitable for self-administration. The pen's design eliminates dosing errors, ensuring you receive precisely 0.25mg each week. Proper storage maintains semaglutide potency, crucial for achieving the appetite suppression and metabolic benefits that build throughout your escalation journey.
First Month Expectations and Starter Dose Success
Your first month on the 0.25mg Wegovy starter dose sets realistic expectations for your weight management journey ahead. Many patients report subtle appetite changes, reduced food cravings, and feeling satisfied with smaller portions during weeks 1-4. Some individuals experience mild nausea, particularly in the first few days after injection, which typically diminishes as your body adapts to semaglutide. These early effects, while modest compared to higher doses, represent important physiological changes that compound throughout your dose escalation.
Success during your starter dose phase involves establishing consistent injection routines, implementing the reduced-calorie diet essential for Wegovy's effectiveness, and tracking your body's responses to guide future dose progression. The starter dose period also allows you to develop the lifestyle habits that amplify semaglutide's effects at higher doses. Remember that this prescription-only medicine works alongside dietary changes and increased physical activity, not as a standalone solution.
Complete Your Wegovy Dose Journey with Confidence
Starting your Wegovy dose journey with the proper 0.25mg foundation ensures optimal results throughout the complete 16-week escalation protocol. New customers can begin immediately using code FIRST40, while returning customers continue their progression with code DOSE25 for ongoing support. Our clinical team remains available throughout your starter dose phase and beyond, helping you navigate any questions about progression, side effects, or lifestyle integration. Visit https://everydaymeds.co.uk/products/wegovy-0-25mg to begin your clinical assessment today and take the first step towards sustainable weight management with the UK's trusted GPhC-registered pharmacy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
